300 results
Page 2 of 15
8-K
EX-99.2
zlf54dbatx6t6f
12 Sep 22
Regulation FD Disclosure
4:09pm
8-K
EX-99.3
v841gf uy1ccb44d
12 Sep 22
Regulation FD Disclosure
4:09pm
8-K
EX-99.01
y378df77cr4g7rdup
6 Sep 22
Other Events
4:07pm
8-K
EX-99.1
a1ilkmhxkw6qvn8
4 Aug 22
Cardiff Oncology Reports Second Quarter 2022 Results and Provides Business Updates
4:08pm
8-K
EX-99.1
vhc5xoa
5 May 22
Cardiff Oncology Reports First Quarter 2022 Results and Provides Business Updates
4:03pm
8-K
EX-99.1
7ohxa88ed70dn8dyje50
12 Apr 22
Cardiff Oncology Announces Departure of Chief Medical Officer
4:11pm
8-K
EX-99.2
ofzar6u
8 Apr 22
Regulation FD Disclosure
3:34pm
8-K
EX-99.1
fprym bfb8uk6axwck5
8 Apr 22
Regulation FD Disclosure
3:34pm
8-K
EX-99.1
71e0i4h5
24 Feb 22
Cardiff Oncology Reports Fourth Quarter and Full Year 2021 Results and Recent Highlights
4:09pm
8-K
EX-99.1
fea7nurjkw
18 Jan 22
Regulation FD Disclosure
5:00pm
8-K
EX-99.1
l17paiacx1zy
11 Jan 22
Cardiff Oncology Appoints Tod Smeal, Ph.D., as Chief Scientific Officer and Charles Monahan, RPh, as Senior Vice President, Regulatory Affairs
10:09am
8-K
EX-99.1
q6dujwf6
3 Dec 21
Other Events
11:05am
8-K
EX-10.1
hk4y8
18 Nov 21
Cardiff Oncology Announces $15 Million Equity Investment from Pfizer through its Pfizer Breakthrough Growth Initiative
8:56am
8-K
EX-99.1
feh3s7035vvmz nf
18 Nov 21
Cardiff Oncology Announces $15 Million Equity Investment from Pfizer through its Pfizer Breakthrough Growth Initiative
8:56am
8-K
EX-99.1
lsj84sq
4 Nov 21
Cardiff Oncology Reports Third Quarter 2021 Results and Provides Business Updates
4:01pm
8-K
EX-99.1
nog3in6q ghcokc
8 Sep 21
Regulation FD Disclosure
4:00pm